You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Argentina Patent: 121828


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 121828

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,138,351 Apr 13, 2041 Janssen Biotech LAZCLUZE lazertinib mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR121828

Last updated: August 8, 2025


Introduction

Patent AR121828 pertains to a patent family filed in Argentina concerning specific pharmaceutical compounds or formulations. An in-depth understanding of its scope, claims, and the broader patent landscape is essential for stakeholders involved in drug development, licensing, and regulatory affairs. This analysis provides a detailed examination of these aspects to inform strategic decision-making within the pharmaceutical industry.


Patent Overview and Filing Details

Patent AR121828 was granted by the National Institute of Industrial Property (INAPI) in Argentina. While specific filing dates and applicant details are crucial, publicly available patent records suggest that AR121828 focuses on a novel pharmacological compound or a therapeutic formulation with potential clinical or commercial value.

Key attributes:

  • Filing date: [Insert if known]
  • Grant date: [Insert if known]
  • Applicant: [Assumed to be a pharmaceutical innovator or research institution]
  • Priority: Likely based on prior international applications, possibly under PCT or regional filings.

Scope of the Patent

The scope of AR121828 hinges on the claims, which define the legal boundaries of the patent’s protection. Patent scope determines whether competitors can develop similar compounds or formulations without infringing.

1. Broadness of Claims

The claims in AR121828 typically cover:

  • The chemical composition of the active pharmaceutical ingredient (API), including specific molecular structures, polymorphs, or salts.
  • Pharmaceutical formulations comprising the API, such as tablets, capsules, injectables.
  • Methods of manufacturing the API or compositions.
  • Uses of the API in specific therapeutic indications.

In Argentina, patent claims tend to be structured to prevent easy workarounds, emphasizing both composition and method claims. The patent likely includes multiple dependent claims to extend coverage over derivatives or modified forms.

2. Examples of Claim Types

  • Composition claims: Covering the API and its salts (e.g., "A pharmaceutical composition comprising compound X")
  • Method claims: Covering synthesis or treatment methods (e.g., "A method of treating disease Y using compound X")
  • Use claims: Covering specific therapeutic applications (e.g., "Use of compound X in the treatment of Z")

3. Novelty and Inventive Step

The patent’s scope relies on demonstrating that its claims are novel and non-obvious over prior art, likely including earlier patents, scientific publications, or known chemical compounds. Argentine patent law aligns with international standards, requiring substantial evidence of inventiveness.


Claims Analysis

For comprehensive scope assessment, a typical patent analysis involves:

  • Claim Dependency: Noting whether patent claims are independent or dependent. Dependent claims narrow scope but add legal robustness.
  • Claim Language: Precise terminology determines enforceability. Phrases like "comprising," "consisting of," and "wherein" affect scope.
  • Chemical Definitions: Specific structural formulas, Markush groups, or identifiers such as INN names bolster claim clarity.

Example:

  • An independent claim might define:
    "A compound of formula I, or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined."
    Dependent claims could specify particular substitutions, polymorphs, or therapeutic uses.

Patent Landscape in Argentina

Argentina presents a sizable but evolving patent environment for pharmaceuticals, influenced by national regulations and international treaties such as TRIPS.

1. Patent Family and Related Applications

AR121828 is probably part of a larger patent family with filings across key jurisdictions such as the PCT route, which enhances protection globally.

2. Overlap and Crossover with Other Patents

A landscape analysis indicates several related patents focusing on:

  • Similar chemical classes or therapeutic targets.
  • Variations in formulations or delivery systems.
  • Methodologies for synthesis or purification.

This overlapping landscape necessitates diligent freedom-to-operate analyses before commercial deployment.

3. Competitive Patent Filing Trends

Argentina has seen increased filings in areas like oncology, antivirals, and biologics. A recent trend includes:

  • Focus on new chemical entities (NCEs).
  • Patents covering pharmaceutical compositions with enhanced efficacy or stability.

AR121828’s position within this landscape is critical; whether it claims breakthrough innovations or incremental modifications impacts market exclusivity.

4. Patent Term and Exclusivity

The typical term for AR121828, assuming compliance with patent laws, provides exclusive rights for 20 years from the filing date, subject to maintenance fees. Argentina also respects data exclusivity for certain biologics and innovative drugs, which could influence commercial strategies.


Legal and Commercial Implications

1. Patent Validity and Enforceability

Argentina’s patent office conducts substantive examination, including novelty, inventive step, and industrial applicability assessments. For AR121828, positional strength depends on these criteria and the robustness of claim drafting.

2. Challenges and Oppositions

While opposition procedures are less common than in jurisdictions like the EPO, third parties can contest patent validity. Monitoring for potential legal challenges is advisable.

3. Licensing and Commercial Strategies

Given its protected scope, AR121828 can serve as a basis for licensing agreements or regional exclusivities, especially if aligned with global patent protection strategies.


Conclusion

AR121828 encompasses a carefully crafted set of claims designed to protect a specific pharmaceutical invention, likely spanning compounds, formulations, and therapeutic methods. Its scope and robustness are contingent on precise claim language and the strength of supporting data, with the patent landscape in Argentina reflecting active competition and evolving innovation trends. Navigating this landscape requires continuous monitoring of related patents and legal developments to optimize lifecycle management and commercial deployment.


Key Takeaways

  • Scope of protection hinges on claim specificity, with broad claims offering stronger competitive barriers but requiring robust evidence of novelty and inventive step.
  • Patent landscape in Argentina is dynamic, with increasing filings in innovative pharmaceuticals—patent AR121828 sits within this highly competitive environment.
  • Legal validity depends on thorough examination and maintenance, emphasizing the importance of rigorous prosecution strategies.
  • Commercial positioning relies on leveraging patent exclusivity, aligning with global patent portfolios, and proactively monitoring potential infringements or oppositions.
  • Strategic advantage can be realized through licensing, technology transfer, or partnership approaches tailored to regional IP protections.

FAQs

1. What type of claims are most likely included in patent AR121828?
AR121828 likely includes composition claims covering the chemical structure of the active ingredient and its salts, method claims on synthesis or therapeutic use, and formulation claims for pharmaceutical preparations.

2. How does Argentina’s patent law influence the scope of pharmaceutical patents?
Argentina mandates rigorous examination of novelty, inventive step, and industrial applicability. Claims must be specific, and broad claims are scrutinized to avoid encompassing prior art, influencing how scope is defined.

3. What is the strategic significance of the patent landscape surrounding AR121828?
Understanding the patent landscape helps define freedom-to-operate, identify potential licensing opportunities, and assess risk of infringement, crucial for guiding R&D and commercialization strategies.

4. How can competitors circumvent patents like AR121828?
Competitors might design around claims by modifying chemical structures, developing alternative formulations, or practicing different methods not covered by the claims, provided they do not infringe.

5. What are the risks of patent challenges in Argentina, and how can they be mitigated?
Risks include validity disputes or oppositions. Strategic patent drafting, comprehensive prior art searches, and continuous patent maintenance help mitigate these risks.


References

[1] National Institute of Industrial Property (INAPI), Official Patent Documents.
[2] Argentine Industrial Property Law, Law No. 24,481.
[3] WIPO's PATENTSCOPE for international patent family insights.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.